Antagonism	antagonism	O	O	O	O
of	of	O	O	O	O
diazepam-induced	diazepam-induced	O	O	O	O
sedative	sedative	O	O	O	O
effects	effects	O	O	O	O
by	by	O	O	O	O
Ro15	ro15	O	O	OTHERS	I
-	-	O	O	OTHERS	I
1788	1788	O	O	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
after	after	O	O	O	O
surgery	surgery	O	O	O	O
under	under	O	O	O	O
lumbar	lumbar	O	O	O	O
epidural	epidural	O	O	O	O
block	block	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
double-blind	double-blind	O	O	O	O
placebo-controlled	placebo-controlled	O	O	O	O
investigation	investigation	O	O	O	O
of	of	O	O	O	O
efficacy	efficacy	O	O	O	O
and	and	O	O	O	O
safety	safety	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
aim	aim	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
was	was	O	O	O	O
to	to	O	O	O	O
assess	assess	O	O	O	O
the	the	O	O	O	O
efficacy	efficacy	O	O	O	O
of	of	O	O	O	O
Ro15	ro15	O	O	OTHERS	I
-	-	O	O	OTHERS	I
1788	1788	O	O	OTHERS	I
and	and	O	O	O	O
a	a	O	O	O	O
placebo	placebo	O	O	O	O
in	in	O	O	O	O
reversing	reversing	O	O	O	O
diazepam-induced	diazepam-induced	O	O	O	O
effects	effects	O	O	O	O
after	after	O	O	O	O
surgery	surgery	O	O	O	O
under	under	O	O	O	O
epidural	epidural	O	O	O	O
block	block	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
to	to	O	O	O	O
evaluate	evaluate	O	O	O	O
the	the	O	O	O	O
local	local	O	O	O	O
tolerance	tolerance	O	O	O	O
and	and	O	O	O	O
general	general	O	O	O	O
safety	safety	O	O	O	O
of	of	O	O	O	O
Ro15	ro15	O	O	OTHERS	I
-	-	O	O	OTHERS	I
1788	1788	O	O	OTHERS	I
.	.	O	O	O	O

Fifty-seven	fifty-seven	O	O	O	O
patients	patients	O	O	O	O
were	were	O	O	O	O
sedated	sedated	O	O	O	O
with	with	O	O	O	O
diazepam	diazepam	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
surgery	surgery	O	O	O	O
under	under	O	O	O	O
epidural	epidural	O	O	O	O
anaesthesia	anaesthesia	O	O	O	O
.	.	O	O	O	O

Antagonism	antagonism	O	O	O	O
of	of	O	O	O	O
diazepam-induced	diazepam-induced	O	O	O	O
effects	effects	O	O	O	O
by	by	O	O	O	O
Ro15	ro15	O	O	OTHERS	I
-	-	O	O	OTHERS	I
1788	1788	O	O	OTHERS	I
was	was	O	O	O	O
investigated	investigated	O	O	O	O
postoperatively	postoperatively	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
double-blind	double-blind	O	O	O	O
placebo-controlled	placebo-controlled	O	O	O	O
trial	trial	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
patient	patient	O	O	O	O
's	's	O	O	O	O
subjective	subjective	O	O	O	O
assessment	assessment	O	O	O	O
of	of	O	O	O	O
mood	mood	O	O	O	O
rating	rating	O	O	O	O
,	,	O	O	O	O
an	an	O	O	O	O
objective	objective	O	O	O	O
test	test	O	O	O	O
of	of	O	O	O	O
performance	performance	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
test	test	O	O	O	O
for	for	O	O	O	O
amnesia	amnesia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
vital	vital	O	O	O	O
signs	signs	O	O	O	O
were	were	O	O	O	O
recorded	recorded	O	O	O	O
for	for	O	O	O	O
up	up	O	O	O	O
to	to	O	O	O	O
300	300	O	O	O	O
min	min	O	O	O	O
after	after	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
trial	trial	O	O	O	O
drug	drug	O	O	O	O
.	.	O	O	O	O

No	no	O	O	O	O
significant	significant	O	O	O	O
differences	differences	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
two	two	O	O	O	O
groups	groups	O	O	O	O
were	were	O	O	O	O
observed	observed	O	O	O	O
for	for	O	O	O	O
mood	mood	O	O	O	O
rating	rating	O	O	O	O
,	,	O	O	O	O
amnesia	amnesia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
or	or	O	O	O	O
vital	vital	O	O	O	O
signs	signs	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
Ro15	ro15	O	O	OTHERS	I
-	-	O	O	OTHERS	I
1788	1788	O	O	OTHERS	I
group	group	O	O	O	O
showed	showed	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
improvement	improvement	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
performance	performance	O	O	O	O
test	test	O	O	O	O
up	up	O	O	O	O
to	to	O	O	O	O
120	120	O	O	O	O
min	min	O	O	O	O
after	after	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
drug	drug	O	O	O	O
.	.	O	O	O	O

There	there	O	O	O	O
was	was	O	O	O	O
no	no	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
reaction	reaction	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
injection	injection	O	O	O	O
site	site	O	O	O	O
.	.	O	O	O	O

